Advertisement

The Scientist

» pharmaceuticals

Most Recent

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

image: Opinion: Reasons for the R&D Crisis

Opinion: Reasons for the R&D Crisis

By | September 23, 2013

Response to an opinion in The Scientist charting current pitfalls in translational research

2 Comments

image: Pharma Moves Toward Transparency

Pharma Moves Toward Transparency

By | July 29, 2013

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

0 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

image: NIH to Resurrect Old Drugs

NIH to Resurrect Old Drugs

By | June 20, 2013

Academic scientists and the pharmaceutical industry will collaborate on a new program to speed up the drug development process.

0 Comments

image: Top GSK Scientist Fired Over Paper

Top GSK Scientist Fired Over Paper

By | June 19, 2013

The head of GlaxoSmithKline’s Shanghai neurodegenerative-disease research unit is axed after irregularities are uncovered in a 2010 paper he published.

0 Comments

image: Release of Drug Data Blocked

Release of Drug Data Blocked

By | May 2, 2013

A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.

0 Comments

image: AstraZeneca Downsizing R&D Staff

AstraZeneca Downsizing R&D Staff

By | March 19, 2013

Positions for 1,600 scientists at the pharmaceutical company will be eliminated globally.

0 Comments

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: Antibody-Drug Combo Approved

Antibody-Drug Combo Approved

By | February 25, 2013

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

0 Comments

Advertisement
TECA Corporation
TECA Corporation

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Neanderthal-Human Hybrid Unearthed
  3. Sex Differences in Pain Pathway
  4. Antibiotics and the Gut Microbiome
Advertisement
The Scientist